Technology areas: Biotechnology & Pharmaceuticals • Communications
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
BIOLEGEND, Inc. has 1 pending office action in Communications. The matter is assigned to 1 distinct examiner in 1 distinct art unit.
MAZUMDER, TAPAS is the busiest examiner, with 1 pending office action. Counsel can focus directly on the examiner’s stated issues and the communications technology addressed by the application.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MAZUMDER, TAPAS | 1 | 82.1% | +17.0% |
| RAYMONDA, MATTHEW HAROLD | 1 | 40.0% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17908821 | METHODS AND COMPOSITIONS FOR DETECTING TARGETS | RAYMONDA, MATTHEW HAROLD | 33d |
| 19015300 | VISUALIZING INTRA-CELL CO-EXPRESSION OF CELLULAR CONSTITUENTS USING DIMENSIONALITY REDUCTION THAT IS WEIGHTED BY CELL TYPE | MAZUMDER, TAPAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17908821 | METHODS AND COMPOSITIONS FOR DETECTING TARGETS | RAYMONDA, MATTHEW HAROLD | 33d |
| 19015300 | VISUALIZING INTRA-CELL CO-EXPRESSION OF CELLULAR CONSTITUENTS USING DIMENSIONALITY REDUCTION THAT IS WEIGHTED BY CELL TYPE | MAZUMDER, TAPAS | — |
| Art Unit | Apps |
|---|---|
| 2615 | 1 |
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19015300 | VISUALIZING INTRA-CELL CO-EXPRESSION OF CELLULAR CONSTITUENTS USING DIMENSIONALITY REDUCTION THAT IS WEIGHTED BY CELL TYPE | MAZUMDER, TAPAS | 2615 | §102§103 | Final Rejection | — | Pending | Jan 09, 2025 |
| 17908821 | METHODS AND COMPOSITIONS FOR DETECTING TARGETS | RAYMONDA, MATTHEW HAROLD | 1684 | §103§112 | Final Rejection | 33d | Pending | Sep 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBIOLEGEND, Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Tapas Mazumder has the most, with 1 of BIOLEGEND, Inc.'s pending office actions.
Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.
